Aether Therapeutics Inc. — Form D
Aether Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-19. The offering totals $6.6M, of which $4.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-01-19
- Form: D
- Accession: 0002004745-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $4.1M
- Remaining: $2.5M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2024-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-502978
Issuer
- Name: Aether Therapeutics Inc.
- CIK: 0002004745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4200 MARATHON BOULEVARD, AUSTIN, TX, 78756
- Phone: 760-783-3085
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| John D Harris | Director | Austin, TX |
| Eric K Olson | Director | Washington, UT |
| Wolfgang S Sadee | Director | Austin, TX |
| Jon S Saxe | Director | Austin, TX |
| John D Harris | Executive Officer | Austin, TX |
| Jon S Saxe | Executive Officer | Austin, TX |
More